NCT01689571View on ClinicalTrials.gov

A Study to Evaluate the Efficacy After Allergen Challenge, Safety and Tolerability of Inhaled CHF6001 DPI in Asthmatics

PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions
Asthma
Interventions
DRUG

CHF6001

DRUG

Placebo

Trial Locations (3)

Unknown

Hammersmith Medicines Research, London

Respiratory Clinical Trials, London

Medicines Evaluation Unit, Manchester

All Listed Sponsors
lead

Chiesi Farmaceutici S.p.A.

INDUSTRY

NCT01689571 - A Study to Evaluate the Efficacy After Allergen Challenge, Safety and Tolerability of Inhaled CHF6001 DPI in Asthmatics | Biotech Hunter | Biotech Hunter